Ras Signaling in Cancer Nanocourse

Wednesday, November 13, 2013 at 1:00pm to 4:00pm

Goldenson Building, 122 220 longwood avenue

Nanocourse Faculty: Karen Cichowski, Kevin Haigis, William Hahn
Curriculum Fellow: Meg Mittelstadt, meganmittelstadt@gmail.com

At least 15% of all human cancers possess mutations in Ras oncogenes; however, mutations in upstream regulators and downstream effectors are also prevalent. In total, the Ras pathway is deregulated in the majority of human cancers.  Nevertheless, while Ras has been extensively studied for 30 years, it is still unknown how this pathway drives human cancer. In this nanocourse, we will compare and contrast Ras signaling and its regulation in both normal and cancer cells with an emphasis on recent novel discoveries. Current and future therapeutics that target Ras or Ras-dependent pathways will also be discussed.

Event Type

Basic Science



Event Contact Name

Megan Mittelstadt

Event Contact Email


Event Contact Phone


Recent Activity

People Going

Getting Here